Athira Pharma, Inc. (ATHA) Return On Equity % [USD] 2020 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Athira Pharma, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2024.
  • Athira Pharma, Inc. Return On Equity for the quarter ending March 31, 2024 was -80.6 %, a 94.5% decline year-over-year.
  • Athira Pharma, Inc. annual Return On Equity for 2023 was -69.1 %, a 95.1% decline from 2022.
  • Athira Pharma, Inc. annual Return On Equity for 2022 was -35.4 %, a 121% decline from 2021.
  • Athira Pharma, Inc. annual Return On Equity for 2021 was -16 %, a 0.19% decline from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -80.6 -39.2 -94.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -69.1 -33.7 -95.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -61.3 -33.3 -118% Jul 1, 2023 Sep 30, 2023
Q2 2023 -48.2 -23.3 -93.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -41.4 -21 -103% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35.4 -19.4 -121% Oct 1, 2022 Dec 31, 2022
Q3 2022 -28.1 -14.1 -101% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25 -12.4 -99.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -20.5 -8.23 -67.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -16 -0.03 -0.19% Oct 1, 2021 Dec 31, 2021
Q3 2021 -14 Jul 1, 2021 Sep 30, 2021
Q2 2021 -12.5 Apr 1, 2021 Jun 30, 2021
Q1 2021 -12.2 Jan 1, 2021 Mar 31, 2021
Q4 2020 -16 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.